参考文献/References:
[1] 张玉婷,孟海霞.妊娠期糖尿病流行病学调查 [J].世界最新医学信息文摘(连续型电子期刊), 2019,19(99):95-97.ZHANG Yuting ,MENG Haixia .A prevalence surveyon gestational diabetes mellitus[J]. World LatestMedicine Information(Continuous ElectronicJournal), 2019,99(19):95-97.
[2] 黄裕春.糖尿病患者胰岛素、C 肽释放、糖耐量和糖化血红蛋白联合测定分析 [J]. 临床医学工程 ,2016, 23(2):175-176.HUANG Yuchun. Combined detection of insulin,C-peptide release, glucose tolerance and glycated he-moglobin of diabetic patients[J].Clinical Medical Engi-neering, 2016, 23(2):175-176.
[3] 吕朝晖 , 潘长玉 , 高妍 , 等 . 随机、双盲、安慰剂对照评价盐酸吡格列酮并用磺酰脲类药物治疗 2 型糖尿病的有效性和安全性 [J].中华内科杂志 , 2011,50(10):826-830.L? Zhaohui, PAN Changyu, GAO Yan, et al. Arandomized, double blind, placebo-controlled, paralleland multicenter study to evaluate the safety and efficacyof pioglitazone with sulphonyurea in type 2 diabeticpatients[J].Chinese Journal of Internal Medicine, 2011,50(10): 826-830.
[4] VILELA B S, ANA CAROLINA J V, ROBERTASOARES L C, et al. The HOMA-ddiponectin(HOMA-AD) closely mirrors the HOMA-IR indexin the screening of insulin resistance in the Brazilianmetabolic syndrome study (BRAMS)[J]. PLoS One,2016, 11(8): e0158751.
[5] KUSUNOKI Y, KATSUNO T, NAKAE R, et al.Insulin resistance and β-cell function influencepostprandial blood glucose levels in Japanese patientswith gestational diabetes mellitus[J]. GynecologicalEndocrinology, 2015, 31(12): 929-933.
[6] 梁培松,王结珍,陈康,等.孕早期年龄 ,BMI 和PAPPA 水平综合评价对 GDM 的预测价值 [J]. 现代检验医学杂志 , 2020, 35(1): 133-135.LIANG Peisong,WANG Jiezhen,CHEN Kang,et al.Predictive value of comprehensive evaluation of earlypregnant age, BMI and PAPPA levels to the GDM[J].Journal of Modern Laboratory Medicine, 2020,35 (1):133-135.
[7] ZHU Weiwei, YANG Huixia, WANG Chen, et al. Highprevalence of gestational diabetes mellitus in Beijing:effect of maternal birth weight and other risk factors[J].Chinese Medical Journal, 2017, 130(9): 1019-1025.
[8] 陈翠美.深圳市妇幼保健院 2018 年上半年妊娠期糖尿病发病率调查 [J]. 医药前沿 , 2019, 9(13):232.CHEN Cuimei. Investigation of diabetes incidence ofpregnant women in child health care hospital of Shen-zhen in half of 2018 [J].Journal of Frontiers of Medi-cine, 2019,9(13):232.
[9] BLATT A J, NAKAMOTO J M, KAUFMAN H W.Gaps in diabetes screening during pregnancy andpostpartum[J]. Obstetrics and Gynecology, 2011,117(1): 61-68.
[10] 谢君芬 . 妊娠期糖尿病发病机制的研究现状 [J]. 临床医药文献(电子杂志), 2020,7(8):196.XIE Junfen. The research status of gestational diabetesmellitus[J]. Journal of Clinical Medical Literature(Electronic Edition), 2020,7(8):196.
[11] 沈文霞 . 妊娠期糖尿病与新生儿胰岛素抵抗的相关性研究 [J]. 中国现代医生 , 2018, 56(3): 12-14, 18.SHEN Wenxia. Correlation between gestationaldiabetes mellitus and neonatal insulin resistance[J].China Modern Doctor, 2018, 56(3):12-14, 18.
相似文献/References:
[1]黄金文,李如凯,高 婧,等.孕妇血清半胱氨酸蛋白酶抑制剂C参考范围的研究[J].现代检验医学杂志,2016,31(04):133.[doi:10.3969/j.issn.1671-7414.2016.04.039]
HUANG Jin-wen,LI Ru-kai,GAO Jing,et al.Study on the Reference Interval of Serum Cystatin C of Pregnant Women[J].Journal of Modern Laboratory Medicine,2016,31(06):133.[doi:10.3969/j.issn.1671-7414.2016.04.039]
[2]郝玉萍,薛金莲,樊阳阳,等.孕妇血清生物素水平与胎儿生长及早产的相关性分析[J].现代检验医学杂志,2021,36(02):148.[doi:doi:10.3969/j.issn.1671-7414.2021.02.035]
HAO Yu-ping,XUE Jin-lian,FAN Yang-yang,et al.Analysis of Correlation between Serum Biotin Level and Fetal Growth and Premature Delivery in Pregnant Women[J].Journal of Modern Laboratory Medicine,2021,36(06):148.[doi:doi:10.3969/j.issn.1671-7414.2021.02.035]
[3]康 茹,成晓悦,王 琪,等.化学发光免疫法分析孕妇血清甲状腺球蛋白抗体浓度分布及其对甲状腺球蛋白水平检测的影响研究[J].现代检验医学杂志,2023,38(01):165.[doi:10.3969/j.issn.1671-7414.2023.01.031]
KANG Ru,CHENG Xiao-yue,WANG Qi,et al.Study on the Distribution of Serum Thyroglobulin Antibody in Pregnant Women by Chemiluminescence Immunoassay and Its Interference on the Detection of Thyroglobulin[J].Journal of Modern Laboratory Medicine,2023,38(06):165.[doi:10.3969/j.issn.1671-7414.2023.01.031]
[4]夏爱军,樊文昕,黄珊珊,等.孕妇血清高效价IgG 血型抗体亚型分析与胎儿新生儿溶血病及高胆红素血症发生率的相关性研究[J].现代检验医学杂志,2023,38(02):181.[doi:10.3969/j.issn.1671-7414.2023.02.034
]
XIAai-jun,FAN Wen-xin,HUANG Shan-shan,et al.Analysis of High Titer IgG Blood Group Antibody Subtype in Pregnant Women’s Serum and Its Correlation with the Incidence of Hemolytic Disease and Hyperbilirubinemia of the Fetus and Newborn[J].Journal of Modern Laboratory Medicine,2023,38(06):181.[doi:10.3969/j.issn.1671-7414.2023.02.034
]